Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
申请人:Lycera Corporation
公开号:US10189777B2
公开(公告)日:2019-01-29
The invention provides benzenesulfonamido and related compounds, pharmaceutical compositions, methods of promoting RORγ activity, increasing the amount of IL-17 in a subject, and treating cancer using such benzenesulfonamido and related compounds.
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF ROR AND THE TREATEMENT OF DISEASE
申请人:Lycera Corporation
公开号:EP3209641A2
公开(公告)日:2017-08-30
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
申请人:Lycera Corporation
公开号:US20170190659A1
公开(公告)日:2017-07-06
The invention provides benzenesulfonamido and related compounds, pharmaceutical compositions, methods of promoting RORγ activity, increasing the amount of IL-17 in a subject, and treating cancer using such benzenesulfonamido and related compounds.
COMPOUNDS AND METHODS FOR TREATING CANCER
申请人:ANTIDOTE IP HOLDINGS, LLC
公开号:US20200299282A1
公开(公告)日:2020-09-24
Substituted cinnamamide compounds and analogs, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or ameliorate cancer are provided.